deferasirox has been researched along with Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CS; Chang, MC; Chang, TK; Chen, TY; Chen, YC; Chiou, TJ; Hwang, WS; Ko, BS; Lin, SF; Lu, YC; Yeh, SP | 1 |
| Scheinfeld, N | 1 |
1 review(s) available for deferasirox and Dermatoses
| Article | Year |
|---|---|
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles | 2007 |
1 trial(s) available for deferasirox and Dermatoses
| Article | Year |
|---|---|
Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan.
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Deferasirox; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Iron Overload; Male; Middle Aged; Myelodysplastic Syndromes; Skin Diseases; Taiwan | 2019 |